Chronic Kidney Disease Requiring Dialysis

• FDA approval · 2021-02-11
  FDA Approved: PARSABIV — Supplemental Application (Amgen, Inc)

  FDA approved a supplemental application for PARSABIV (etelcalcetide) from Amgen, Inc., updating the labeling as part of the supplemental sub…